TheBCR/ABL fusion gene produces p210 Bcr-Abl, a constitutively active kinase; CML patients may present Bcr-Abl transcript variants. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.